Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment

Abstract

SNM is a suitable treatment option in those patients who have had prior BTXA treatment for refractory OAB, even in those for whom BTXA proved ineffective. Success rates were within the published range, and comparable to our own results, for SNM in OAB patients without prior BTXA treatment.